Condition
Sensory Neuropathy
Total Trials
6
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06078527Not ApplicableNot Yet Recruiting
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
NCT05483816Not ApplicableRecruiting
MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts
NCT06183008Phase 4Not Yet RecruitingPrimary
IVIG in Painful Sensory Neuropathy
NCT05721040Completed
Short-term Evaluation of Motor and Sensory Function in Post-COVID-19 Patients
NCT02555930Completed
Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO Study
NCT02451722Not ApplicableCompleted
Evaluation of Pressure Distribution of Kyboot Shoes in Comparison to Other Foot Wear
Showing all 6 trials